SCHEMBL30808196

SCHEMBL30808196

Cc1cc([C@@H](C)N)c2nc(N3CCOCC3)c(C)nc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ PRKDC P78527 1/20 0.39
▸ NUDT1 P36639 1/20 0.39
▸ PIM1 P11309 1/20 0.38
▸ PIM2 Q9P1W9 1/20 0.38
▸ CRHBP P24387 1/20 0.38
▸ CRHR2 Q13324 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ATM Q13315 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ POLB P06746 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HPGD P15428 1/20 0.35
▸ KHK P50053 1/20 0.35
▸ CRHR1 P34998 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ PIK3CA P42336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30808205 1.00 ALDH1A1 (0.40) ALDH1A1KMT2AMEN1PRKDCNUDT1
SCHEMBL30808188 0.88 CYP1A2 (0.47) ALDH1A1KMT2AMEN1PRKDCNUDT1
SCHEMBL30808156 0.79 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1NUDT1PIM1
SCHEMBL30808207 0.79 MET (0.44) ALDH1A1KMT2ACRHBPCRHR2GAA
SCHEMBL30808147 0.78 PIK3CB (0.33) ALDH1A1KMT2AMEN1PIM1PIM2
SCHEMBL30808144 0.75 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1PRKDCNUDT1
SCHEMBL30762612 0.75 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL30808202 0.73 FFAR2 (0.35) —
SCHEMBL31284292 0.73 MEN1 (0.36) KMT2AMEN1PRKDCATMPIK3CA
SCHEMBL31183501 0.72 PIK3CA (0.51) PRKDCPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026419-A1 QUINOXALINE DERIVATIVES AS PIK3 ALPHA MODULATORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback